학술논문
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Document Type
article
Author
Source
RMD Open, Vol 8, Iss 1 (2022)
Subject
Language
English
ISSN
2056-5933